Epsilon Shrinkage and Residual Error
Learn how epsilon shrinkage relates to residual unexplained variability in population PK models, why it occurs, how to interpret it, and how high residual error shrinkage can affect diagnostics and model-based inference.
Empirical Bayes Estimates in Population PK
Learn how empirical Bayes estimates are obtained in population pharmacokinetic models, how individual parameters combine population information with individual concentration data, and how shrinkage affects interpretation and diagnostics.
Covariate Selection Strategies in Population PK
Learn practical covariate selection strategies in population pharmacokinetic modeling, including graphical exploration, forward inclusion, backward elimination, likelihood-based criteria, clinical relevance, shrinkage, and model qualification.
Covariate Modeling in Population PK
Learn how covariates such as body weight, age, renal function, and formulation are incorporated into population pharmacokinetic models to explain variability in clearance, volume, and other PK parameters.
Continuous Covariates and Functional Forms
Learn how continuous covariates such as body weight, age, renal function, and laboratory measurements are incorporated into population pharmacokinetic models, including linear, power, exponential, and other functional forms.
Categorical Covariates in Population PK
Learn how categorical covariates such as sex, treatment group, genotype, formulation, and disease status are incorporated into population pharmacokinetic models, including coding, parameter interpretation, model building, and common mistakes.
Bootstrap Validation of Population PK Models
Learn how bootstrap validation evaluates population pharmacokinetic models by repeatedly resampling subjects, refitting the model, assessing parameter uncertainty and bias, and evaluating model stability.
Body Weight as a PK Covariate
Learn how body weight is incorporated as a covariate in population pharmacokinetic models, including allometric scaling, clearance and volume relationships, model interpretation, and practical examples.
Body Size Descriptors in PK Modeling
Learn how body weight, lean body weight, fat-free mass, body surface area, and other size descriptors are used as covariates in pharmacokinetic modeling, including allometric scaling and practical model-building considerations.
Allometric Scaling in Population Pharmacokinetics
Learn how allometric scaling incorporates body size into population pharmacokinetic models, including standard allometric exponents for clearance and volume, covariate modeling, interpretation, worked examples, and common mistakes.